Covaxil Laboratories Review
What You Should Know
Covaxil Laboratories is the manufacturer of a weight loss supplement marketed towards premenopausal and menopausal women. The product is called Estrin D. Limited information is available about Covaxil Laboratories corporate information. It is said that Covaxil Laboratories is committed to developing a weight loss product specifically designed to meet the needs of premenopausal and menopausal women. Menopausal and premenopausal women find that their metabolism is slowing, fat is redistributing throughout the body, have an increased risk of osteoporosis, suffer from hot flashes and mood swings. Estrin-D was developed to combat these symptoms and increase weight loss in these women. Covaxil Laboratories recognizes that these women’s needs are different than younger women and men, and claims to fill that need.
Not applicable. Covaxil Laboratories manufactures only one product, Estrin-D.
Covaxil Laboratories is the manufacturer of Estrin-D, a weight loss supplement for women who are menopausal or premenopausal. It contains Yerba Mate Leaf, Caffeine, Guarana Seed, Damiana Leaf and Stem, Green Tea Leaf, Ginger, Kola Nut, SHEA, Schisandra Fruit, Scutellaria, Tibetan Ginseng Root, Cacao Nut, Jujube and Thea Sinensis Complex. The yerba mate, caffeine, guarana, and green tea are all stimulants. This can cause side effects, such as increased heart rate, increased blood pressure, jitters and insomnia. The dosing recommendations are 1-2 tablets 15-30 minutes before large meals, not to exceed 6 tablets in 24 hours. Consumers sensitive to caffeine and other stimulants should take just 1 tablet before meals until they know how it will affect them.
- Covaxil Laboratories product is developed just for menopausal and premenopausal women’s needs.
- Covaxil Laboratories is committed to meeting women’s weight loss needs.
- Covaxil Laboratories does not have a dedicated corporate website.
- Covaxil Laboratories product Estrin-D contains four different stimulants.
- Covaxil Laboratories does not publish clinical study results.
Covaxil Laboratories manufacturers Estrin-D which is a weight loss supplement specifically designed for women who are premenopausal and menopausal. These women’s needs are different than the average consumer looking for a weight loss product. These women have a slowing metabolism, a redistribution of fat cells, mood swings, hot flashes and an increased risk of osteoporosis. The company states that other weight loss supplements will not be effective for women with these symptoms. The Estrin-D contains four different stimulants, so consumers have an increased risk for side effects such as increased heart rate, increased blood pressure, jitters and insomnia. Consumers with chronic health conditions should contact a physician prior to use, especially with the stimulants in this product.
Consumers looking for a weight loss supplement should look for one with both a fat burner and appetite suppressant. This combination, in addition to a sensible diet and exercise will give the consumer the best results. This supplement should have a dedicated website with customer testimonials and clinical trials proving the effectiveness of the product.